{"disease":{"id":"raltitrexed","name":"raltitrexed"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06427005","title":"Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"Meng Qiu","has_results":false},{"nct_id":"NCT05426811","title":"Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"China Medical University, China","has_results":false},{"nct_id":"NCT07327788","title":"QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04761185","title":"Raltitrexed in HIPEC","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Fudan University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}